Employed by the Company as a Principal Scientist, Analytical Development, with compensation for fiscal 2025.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Employed by the Company as a Principal Scientist, Analytical Development, with compensation for fiscal 2025.
Company acquired substantially all assets of BioElectron under an Asset Purchase Agreement; Dr. Klein owns about six percent of BioElectron and is entitled to a portion of payments made to BioElectron under that agreement.
Indemnification agreements under which the Company may indemnify directors and executive officers for expenses, judgments, fines and settlement amounts arising from their service.
Loading...